(Q80404280)
Statements
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma (English)
Hersey P
Halliday GM
Farrelly ML
DeSilva C
Lett M
scientific article published on 01 July 2008